Helicobacter pylori and peptic ulcer recurrence.

Gut ·Vol. 33 ·No. 9 ·1992-09-00 ·Pages 1293

Guslandi M

Abstract

暂无摘要

MeSH Terms

Duodenal Ulcer/prevention & control Helicobacter Infections/drug therapy Helicobacter pylori Humans Organometallic Compounds/therapeutic use Recurrence Sucralfate/therapeutic use

Chemicals

Organometallic Compounds Sucralfate bismuth tripotassium dicitrate

Authors & Affiliations

1 authors, click to expand affiliations / ORCID

Guslandi M

References (6)

6 references, click to expand

The potential impact of Campylobacter pylori on the treatment of duodenal ulcer disease.
Scand J Gastroenterol Suppl. 1989;160:39-45 PMID: 2573145
Cure of duodenal ulcer associated with eradication of Helicobacter pylori.
Lancet. 1990 May 26;335(8700):1233-5 PMID: 1971318
Relapse of duodenal ulcer: does it matter which drug is used in initial treatment?
Br Med J (Clin Res Ed). 1986 Nov 1;293(6555):1117-8 PMID: 3094799
Importance of defensive factors in the prevention of peptic ulcer recurrence. Role of carbenoxolone sodium.
Acta Gastroenterol Belg. 1983 Sep-Oct;46(9-10):411-8 PMID: 6673456
Implications of sucralfate-induced ulcer healing and relapse.
Am J Med. 1989 Jun 9;86(6A):122-6 PMID: 2660554
The choice of ulcer healing agent influences duodenal ulcer relapse rate and long-term clinical outcome.
Aust N Z J Med. 1985 Jun;15(3):367-74 PMID: 3904700

Article Info

Journal

Gut

Abbr.

Gut

ISSN

0017-5749

DOI

10.1136/gut.33.9.1293

Published

1992-09-00

Pages

1293

Language

English

Region

England

NLM ID

2985108R

PMCID

PMC1379506

Subset

Corrections

CommentOn

PMID: 1568643

External Links

PubMed source DOI: 10.1136/gut.33.9.1293 PMC Full Text View journal details

Analysis Services

Helicobacter pylori and peptic ulcer recurrence.

Contact

WeChat Official Account